Sopharma invests in production in Bulgaria and Serbia
This article was originally published in Scrip
Executive Summary
Sopharma, the largest manufacturer of generic drugs in Bulgaria, has started work on a BGN70 million (€35.8 million) local plant two months after it put the first stone into the €8 million; 12,000sq m production facility for solid pharmaceuticals near Belgrade, Serbia.